Erythema Nodosum and Pruritus
Erythema nodosum is typically characterized by tender, painful nodules rather than itchy lesions, with pruritus not being a common or defining symptom of this condition. 1
Clinical Characteristics of Erythema Nodosum
Typical Presentation
- Erythema nodosum presents as raised, tender, erythematous subcutaneous nodules (1-5 cm in diameter)
- Most commonly located on the anterior tibial areas (shins)
- Lesions are typically bilateral and symmetrical 2, 3
- Initially bright red, then evolve to livid red/purplish, and finally exhibit yellow or greenish appearance resembling bruises 3
Key Symptoms
- Pain and tenderness are the predominant symptoms
- Nodules are warm to touch
- Often accompanied by systemic symptoms including:
- Fever
- Arthralgia
- Fatigue 1
What Erythema Nodosum is NOT Associated With
- Pruritus (itching) is not a characteristic feature
- Ulceration never occurs
- Lesions heal without atrophy or scarring 3
Diagnostic Considerations
Physical Examination
- Firm, tender, erythematous subcutaneous nodules
- Typically 1-5 cm in diameter
- Diagnosis is primarily made on clinical grounds 2
- In atypical cases, skin biopsy may be helpful 2
Histopathological Features
- Septal panniculitis without vasculitis
- Thickened septa of subcutaneous fat infiltrated by inflammatory cells
- Presence of Miescher's radial granulomas (small nodular aggregations of histiocytes arranged radially around a central cleft) 3
Differential Diagnosis
When evaluating nodular skin lesions with pruritus, consider these alternative diagnoses:
- Insect bites (typically pruritic)
- Contact dermatitis (often pruritic)
- Urticaria (intensely pruritic)
- Erythema multiforme (may have some pruritus)
- Other forms of panniculitis (may have variable symptoms)
Management Approach
Underlying Cause Identification
- Identify and treat underlying causes 1:
- Streptococcal infections
- Tuberculosis
- Sarcoidosis
- Inflammatory bowel disease
- Behçet's syndrome
- Medication reactions
Treatment Options
- First-line treatment: Colchicine 1
- For severe cases: Systemic corticosteroids 1
- For resistant cases: Immunomodulators (azathioprine, TNF-α antagonists) 1
- Supportive care:
Clinical Pearls
- Erythema nodosum is more common in women than men 1
- Typically self-limited, resolving within 3-6 weeks without scarring 1
- May be the first sign of systemic disease such as tuberculosis, sarcoidosis, or inflammatory bowel disease 4
- Pain, not itching, should guide your diagnostic thinking when considering erythema nodosum
Monitoring and Follow-up
- Regular follow-up to assess treatment response
- Monitor for recurrence after treatment discontinuation
- Evaluate for signs of underlying disease progression 1
In summary, when evaluating a patient with suspected erythema nodosum who reports itching, consider alternative diagnoses, as pruritus is not a typical feature of this condition. The hallmark symptoms are tenderness and pain in the nodular lesions.